Psilocybin (drug) Clinical Trials

5 actively recruiting trials across 3 locations

▲ +1 trial since July 2026

Also known as: 4-phosphoryloxy- N, N-dimethyltryptamine

Pipeline

Phase 1: 1Phase 2: 3Phase 1/2: 1

Top Sponsors

Yale University1
University of California, Los Angeles1
Queen's University1
Jennifer Mitchell1
Beersheva Mental Health Center1

Indications

Depression3
Anhedonia in Healthy Volunteers1
Older Adults (50-90 Years)1
Parkinson's Disease (PD)1
Generalized Anxiety Disorder (GAD)1

Other2 trials

Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression

Phase 2

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Phase 2

Los Angeles, California1 trial

RCT of Psilocybin-assisted CBT for Depression

UCLA Semel Institute

Phase 1/2

San Francisco, California1 trial

A Study of Psychedelics in Healthy Older Adults With Low Well-being

University of California San Francisco, Sandler Neuroscience Building

Phase 1

New Haven, Connecticut1 trial

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

Yale University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.